X4 Pharmaceuticals Inc (XFOR) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
X4 Pharmaceuticals Inc  (NASDAQ: XFOR)


X4 Pharmaceuticals Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is X4 Pharmaceuticals Inc's ROI in the third quarter of 2026?
X4 Pharmaceuticals Inc recorded a cumulative net loss of $-81 million during 12 months ending in the third quarter of 2026, resulting in a negative return on investment (ROI) of -33.49%.

Within the Healthcare sector 427 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 2200 to 3776.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 125.37 % 103.16 % 37.1 % 13.78 % -18.96 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 217 234 247 265 140
Return On Investment (TTM) -33.49 % -40.74 % -54.38 % -53.59 % -89.14 %
XFOR's Overall Ranking # 3776 # 2200 # 3171 # 3691 #
Seq. Investment Change TTM 8.68 % 20.64 % 24.09 % 38.53 % -2.03 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -81 -90 -100 -79 -95

XFOR Company Profile >> Back to XFOR Roi Comparisons >> See Annual XFOR Return On Investment



Return On Investment XFOR's Ranking
Within: No.
Industry # 59
Sector # 428
Overall # 3776

Return On Investment Statistics
High Average Low
13.16 %
-73.49 %
-388.31 %
(Jun 30 2024)   (Jun 30 2019)







Financial Statements
X4 Pharmaceuticals Inc's III. Quarter Investments $ 217 Millions XFOR's Balance sheet
X4 Pharmaceuticals Inc's III. Quarter Income $ -20 Millions Quarterly XFOR's Income Statement
XFOR's Income by Division See XFOR's Income by Division


XFOR Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 265 114 107 133 103
Y / Y Investment Growth 133.08 % 5.81 % -19.46 % 29.19 % -7 %
Net Income in Millions -79 -37 -101 -96 -103
Y / Y Net Income Growth - - - - -
Annual Return On Investment -29.92 % -32.98 % -94.26 % -72.35 % -99.5 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
XFOR's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for XFOR's Competitors
Subscribers only: Roi for X4 Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for XFOR's Customers

Other Ratios
XFOR's Roa XFOR's Inventory Turnover Ratio XFOR's Growth Rates XFOR's Dividend Statistics
XFOR's Profitability Ratios XFOR's Asset Turnover Ratio XFOR's Dividend Growth
XFOR's Roe XFOR's Valuation Ratios XFOR's Financial Strength Ratios XFOR's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI

Date modified: 2026-11-06T12:59:09+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.